Public Reporting of Nursing Home Antipsychotic Use: Changes in the Reporting of Exclusionary Diagnoses?
Date:
Following the public reporting of Antipsychotic Medication (APM) use in nursing homes, we document an increase in prevalence of schizophrenia diagnos, a diagnosis which excludes facilities from the public reporting requirement for these residents. Public reporting is designed to reduce off-label use of APMs, increases in schizophrenia diagnosis are an unintended consequence of the policy that may be attributed to either more accurate diagnosis or upcoding.
Fisher, Megdalynn “Public Reporting of Nursing Home Antipsychotic Use: Changes in the Reporting of Exclusionary Diagnoses?” Oral presentation, O’Neill Ph.D. Student Association Annual Student Research Conference, Bloomington, Indiana, February 17, 2023.